|
- Microsoft Word - causality Website. doc
For drug-drug interactions the WHO-UMC system can be used by assessing the actor drug, which influences the kinetics or dynamics of the other drug (which has usually been taken over a longer period), in the medical context of the patient
- Defined Daily Dose (DDD) - World Health Organization (WHO)
Drug consumption can be expressed in cost, number of units, number of prescriptions or by the physical quantity of drugs However these variables can vary between regions and countries over time This limits comparisons of drug consumption at an international level To address this, a technical unit of measurement, the Defined Daily Dose (DDD) was created
- WHO Drug Information
About WHO Drug Information WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide audience of health professionals and policy makers Launched in 1987, WHO Drug Information communicates the latest international news and trends to regulatory agencies, academic and training institutions, researchers
- Anatomical Therapeutic Chemical (ATC) Classification
In the Anatomical Therapeutic Chemical (ATC) classification system, the active substances are divided into different groups according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties Drugs are classified in groups at five different levels
- Health products policy and standards
Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice throughout the value chain
- Antimicrobial Resistance - World Health Organization (WHO)
As a result of drug resistance, antibiotics and other antimicrobial medicines become inefective and infections become increasingly diicult or impossible to treat
- General guidance on hold‑time studi
1 Introduction and background Manufacturers should ensure that the products that they manufacture are safe, efective and of the quality required for their intended use Systems should be in place to ensure that pharmaceutical products are produced according to validated processes and to defined procedures Manufacturing processes should be shown to be capable of consistently manufacturing
- ECP PR - World Health Organization (WHO)
For finished drug products, the sampling procedure should take ac-count of the official and non-official tests required for the individual dosage form (e g tablets or parenteral preparations) Non-official tests could include testing for adulteration and counterfeiting
|
|
|